Florida's Institute for the Commercialization of Public Research has finalized a funding agreement with Heart Genomics, LLC, a Miami-based early-stage biotechnology company focused on providing non-invasive, genomic-based, clinical diagnostic tests for patients with heart failure.
http://floridabiotechnews.com/biotech/miamis-heart-genomics-receives-loan-funding-from-institute-for-commercialization-of-public-research/11975/?#038;#038;
http://floridabiotechnews.com/biotech/miamis-heart-genomics-receives-loan-funding-from-institute-for-commercialization-of-public-research/11975/?#038;#038;
No comments:
Post a Comment